Anti-SARS-CoV-2 Spike Protein RBD Antibody [2-S21F2] Biosimilar - BSA and Azide free, IgG1, Unconjugated, Human, Monoclonal

Produktübersicht

• Artikelname: Anti-SARS-CoV-2 Spike Protein RBD Antibody [2-S21F2] Biosimilar - BSA and Azide free, IgG1, Unconjugated, Human, Monoclonal
• Artikelnummer: ABC-A339277-100
• Hersteller Artikelnummer: A339277-100
• Alternativnummer: ABC-A339277-100
• Hersteller: Antibodies.com
• Wirt: Human
• Kategorie: Antikörper
• Applikation: ELISA, FC
• Spezies Reaktivität: Virus
• Konjugation: Unconjugated

Produktbeschreibung

Recombinant human monoclonal antibody to SARS-CoV-2 Spike Protein RBD for use as a research grade Anti-RBD Broad-Neutralizing Antibody [002-S21F2] biosimilar.

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [2-S21F2]
• Isotyp: IgG1
• Puffer: Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.
• Reinheit: The purity of this Biosimilar is >95%, as determined by SDS-PAGE.
• Formulierung: Liquid
• Target-Kategorie: SARS-CoV-2 Spike Protein RBD
• Antibody Type: Primary Antibody